Abstract: Disclosed are an auxiliary decision-making method and system for urban subway waterlogging risk disposal based on a Bayesian network. The method includes: acquiring waterlogging data and basic data of a target city subway, preprocessing the waterlogging data, obtaining first evaluation data and second evaluation data from the preprocessed waterlogging data, performing risk assessment on the first evaluation data and the second evaluation data according to risk degrees to obtain a risk value, adjusting the risk value according to the monitoring data to determine a risk degree, and constructing an auxiliary decision-making model for waterlogging risk disposal according to the risk level to optimize the auxiliary decision-making for waterlogging risk disposal.

Abstract: Disclosed are an auxiliary decision-making method and system for urban subway waterlogging risk disposal based on a Bayesian network. The method includes: acquiring waterlogging data and basic data of a target city subway, preprocessing the waterlogging data, obtaining first evaluation data and second evaluation data from the preprocessed waterlogging data, performing risk assessment on the first evaluation data and the second evaluation data according to risk degrees to obtain a risk value, adjusting the risk value according to the monitoring data to determine a risk degree, and constructing an auxiliary decision-making model for waterlogging risk disposal according to the risk level to optimize the auxiliary decision-making for waterlogging risk disposal.

Abstract: A probiotic-encapsulating gum Arabic (GA) composite fiber/capsule, including: lactic acid bacteria and an electrospun fiber or electrosprayed capsule, where the lactic acid bacteria are encapsulated in the electrospun fiber or electrosprayed capsule by electro-hydro dynamics (EHD) technology. The electrospun fiber or electrosprayed capsule is prepared by compounding a polymer matrix with GA, and the polymer matrix is polyvinyl alcohol (PVOH), polyvinylpyrrolidone (PVP), whey protein concentrate (WPC) or maltodextrin (MD). A preparation method and an application of the composite fiber/capsule are also provided.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: A probiotic-encapsulating gum Arabic (GA) composite fiber/capsule, including: lactic acid bacteria and an electrospun fiber or electrosprayed capsule, where the lactic acid bacteria are encapsulated in the electrospun fiber or electrosprayed capsule by electro-hydro dynamics (EHD) technology. The electrospun fiber or electrosprayed capsule is prepared by compounding a polymer matrix with GA, and the polymer matrix is polyvinyl alcohol (PVOH), polyvinylpyrrolidone (PVP), whey protein concentrate (WPC) or maltodextrin (MD). A preparation method and an application of the composite fiber/capsule are also provided.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: Carvedilol parenteral sustained release systems by IV infusion, injection, or subcutaneous routes are disclosed. Preparation of carvedilol disperse systems such as liposomes, biodegradable microparticles or nanoparticles, and polymeric microparticles or nanoparticles have been presented in the present invention. Compositions containing carvedilol encapsulated in liposomes showed higher bioavailability and lower clearance rate than that of the free solution after intravenous administration. In vitro release of those liposomes in buffer solutions shows drug extended release over 48 hours, and correspondingly the in vivo animal data shows that parenteral administration of carvedilol encapsulated in liposomal materials has sustained release PK profile.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: Carvedilol parenteral sustained release systems by IV infusion, injection, or subcutaneous routes are disclosed. Preparation of carvedilol disperse systems such as liposomes, biodegradable microparticles or nanoparticles, and polymeric microparticles or nanoparticles have been presented in the present invention. Compositions containing carvedilol encapsulated in liposomes showed higher bioavailability and lower clearance rate than that of the free solution after intravenous administration. In vitro release of those liposomes in buffer solutions shows drug extended release over 48 hours, and correspondingly the in vivo animal data shows that parenteral administration of carvedilol encapsulated in liposomal materials has sustained release PK profile.

Abstract: A watermark image may be generated that includes a first set of encoded pixels each of which is assigned a first transparency value and a second set of encoded pixels each of which is assigned a second transparency value, the second transparency level being different from the first transparency level. The encoded pixels may be distributed among a set of blank pixels such that each encoded pixel neighbors one or more blank pixels in the watermark image, and in particular at least two blank pixels in the watermark image. Herein, each blank pixel may be assigned the second transparency value. The watermark image may be overlaid and blended over a background source image to create an encoded source image. A decoder system may recover encoded information from the encoded source image.

Abstract: Disclosed herein are novel methods and compositions for targeting ocular diseases. One aspect relates to a contact lens comprising an elastin-like peptide (ELP) component and optionally a therapeutic agent. Also provided are methods for treating ocular diseases comprising administering a contact lens of the disclosure to a subject in need thereof.

Abstract: Carvedilol parenteral sustained release systems by IV infusion, injection, or subcutaneous routes are disclosed. Preparation of carvedilol disperse systems such as liposomes, biodegradable microparticles or nanparticles, and polymeric microparticles or nanparticles have been presented in the present invention. Compositions containing carvedilol encapsulated in liposomes showed higher bioavailability and lower clearance rate than that of the free solution after intravenous administration. In vitro release of those liposomes in buffer solutions shows drug extended release over 48 hours, and correspondingly the in vivo animal data shows that parenteral administration of carvedilol encapsulated in liposomal materials has sustained release PK profile.

Abstract: Described herein are bioresponsive protein polymers for therapeutic applications, including delivery to physiologically demanding environments, such as the eye surface. Bioresponsive protein polymers can be fused with biopharmaceuticals using genetic engineering techniques for enhanced therapeutic activity. In certain embodiments, the unique temperature-sensitive phase separation properties of bioresponsive protein polymers, allows generation of therapeutics resistant to ocular clearance. Such fusion proteins containing bioresponsive protein polymers and biopharmaceuticals allow retention of drugs in the eye for much longer periods of time. Improved biostability and bioavailability improves drug efficacy, while reducing cost and eliminating the need for repeated drug Application.

Abstract: Described herein are bioresponsive protein polymers for therapeutic applications, including delivery to physiologically demanding environments, such as the eye surface. Bioresponsive protein polymers can be fused with biopharmaceuticals using genetic engineering techniques for enhanced therapeutic activity. In certain embodiments, the unique temperature-sensitive phase separation properties of bioresponsive protein polymers, allows generation of therapeutics resistant to ocular clearance. Such fusion proteins containing bioresponsive protein polymers and biopharmaceuticals allow retention of drugs in the eye for much longer periods of time.

Abstract: A mobile terminal according to this invention includes the first calculation module which autonomously calculates its own position based on a GPS signal, and the second calculation module which calculates its own position based on a acquired auxiliary information from a server and the GPS signal. A first control module causes a timer to start a time counting if the second position calculation module accesses the server. When the auxiliary information which satisfies a predetermined condition is not acquired in the time of the timer, the calculation module changes from the second calculation module to the first calculation module. The second control module determines the connection state with the server within the time of the timer. At the time point if the second control module determines that the connection state is an auxiliary information unobtainable state, the calculation module changes from the second calculation module to the first calculation module.

Abstract: According to one embodiment, a portable terminal includes: a display unit that displays a present location of the portable terminal; a GPS receiver that calculates theoretical precision data determined theoretically by geometric arrangement of plural GPS satellites on the basis of location information of the GPS satellites, and performs a positioning process by which positioning data for indicating the present location of the portable terminal is calculated using arrival time of the radio wave; and a control unit that repeats the positioning process performed by the GPS receiver plural times to calculate a cumulative average of the positioning data, and calculates a difference between the cumulative average of the theoretical precision data and the cumulative average of the positioning data to display a cumulative average of the positioning data, when the difference equal to or less than a predetermined value successively continues predetermined number of times, as the present location of the portable termina

Abstract: A mobile apparatus including: a communication module; a first memory and a second memory configured to record first and second information respectively including at least home network information or home country information, the second information different from the first information; an information authentication module configured to determine whether the first and second information is valid or not through the communication module; a limiting module configured to limit a function of the mobile apparatus; a roaming module configured to perform roaming communication between networks; and a network control module configured to: permit the mobile apparatus to make a terminal operation using the second information when the first information is valid; and permit the mobile apparatus to make a terminal operation limited by the limiting module when the first information is invalid.

Abstract: According to one embodiment, a portable terminal includes: a display unit that displays a present location of the portable terminal; a GPS receiver that calculates theoretical precision data determined theoretically by geometric arrangement of plural GPS satellites on the basis of location information of the GPS satellites, and performs a positioning process by which positioning data for indicating the present location of the portable terminal is calculated using arrival time of the radio wave; and a control unit that repeats the positioning process performed by the GPS receiver plural times to calculate a cumulative average of the positioning data, and calculates a difference between the cumulative average of the theoretical precision data and the cumulative average of the positioning data to display a cumulative average of the positioning data, when the difference equal to or less than a predetermined value successively continues predetermined number of times, as the present location of the portable termina